Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.

Johnson & Johnson recently changed the game for contact lens wearers suffering from allergic eye itch by winning FDA approval for a drug-eluting contact lens. Now, medtech analysts at Needham & Co.